Russia granted regulatory approval to a second Covid-19 vaccine, according to the country’s register of authorized medicines.
Johnson & Johnson temporarily paused the company’s Covid-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, delaying one of the highest-profile efforts to contain the global pandemic.
Moncef Slaoui, the head of Operation Warp Speed – the government project to push along the Covid-19 vaccine development – suggested the first Emergency Use Authorization (EUA) for a vaccine will likely be around Thanksgiving.
Drug companies’ political committees have largely donated to Republican presidential campaigns since 1990, but that trend has noticeably reversed come the 2020 election cycle, according to a new report from the Center for Responsive Politics.
The European Union sealed a deal with Johnson & Johnson to supply up to 400 million doses of the company’s potential Covid-19 vaccine, as the bloc builds up stocks amid a global scramble to secure shots.
Enough doses of a coronavirus vaccine could be manufactured by March to April 2021 for every American who wants one, U.S. Health and Human Services Secretary Alex Azar said on Thursday.
Moderna Inc. will soon apply for real-time reviews of the experimental Covid-19 vaccine MRNA-1273 in Europe, the drug developer said, days after the EU health regulator launched rolling reviews of shots from the biotechnology company’s rivals.
2019 was a good year for the pharma industry, even as questions on value kept coming; but 2020 brought a pandemic that raised an “all hands on deck” attitude as well as business challenges.
The European health regulator is reviewing a Covid-19 vaccine being developed by Pfizer and BioNTech in real time, days after launching a similar assessment process for AstraZeneca’s vaccine.
A vaccine against Covid-19 may be ready by year-end, the head of the World Health Organization (WHO) said, without elaborating.
